Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 5 November 2026.

Announcements

6,266

Total raised

£165B

disclosed amounts

This month

£202M

raised so far

Seed
€4.0M

The seed round was co-led by Contrarian Ventures and Anthemis to support international expansion and product development.

"The market was not going in the right direction. We noticed this personally when charging our car and visiting one charging station: depending on the payment method, you end up paying 50 different prices. That realisation came through a personal issue we experienced. In general, EV charging was inaccessible, complicated, and not user-friendly or user-centric — that’s why we created Cariqa."
— Issam Tidjani
Pre-Seed
£1.2M

The pre-seed round was led by Two Magnolias to support the sports technology startup as it launches across Europe.

"We are absolutely thrilled to be leading this round for Movetru. Naomi and her team are solving a critical gap in sports performance with grit, vision, and world-class execution. Movetru represents the best of Northern Ireland’s tech talent, and we are excited to back them on this journey."
— Jessica Rasmussen, Co-Founder and CEO
Series B
£12.0M

The Series B round was co-led by Mundi Ventures and Opera Tech Ventures to support international growth and product scaling.

"We have been at the forefront of shaping digital automotive insurance solutions. Our approach to innovation, with a focus on exceptional user experience, has attracted and retained globally recognisable partners, demonstrating the value in our propositions."
— Nimeshh Patel, CEO
Series A
£3.3M

The investment was led by Whiterock with participation from regional funds and angel backers.

"There is a substantial unmet need today in neuroscience clinical studies. Many study endpoints are measured with traditional pen and paper assessments which lack objective data about brain function. Biopharma companies need objective data to effectively establish baseline information about whether a drug is engaging with the region of the brain that a particular drug is targeting, whether a drug is effective, and informing which cohort of patients may benefit the most from a particular drug."
— Tina Sampath, Chief Executive
Seed
£3.7M

The funding round was led by Amadeus Capital Partners and Edge Ventures to support international growth.

"This is a pivotal moment for Pimloc. We’re scaling rapidly into new sectors, regions, and multimodal workflows, and this investment is a strong endorsement of the platform we’ve built and the category we’re defining. Each investor brings strategic insight – whether in AI, industry-specific domains, or international expansion – that goes well beyond capital. Their backing strengthens our ability to grow thoughtfully, unlock new high-impact use cases, and deliver the infrastructure the world needs for privacy-first AI."
— Simon Randall, CEO